## Abstract ## BACKGROUND Patients affected by neurofibromatosis type 1 (NF1) are at higher risk of developing softβtissue sarcomas (STS) than the general population. The clinical findings and outcome in 43 children and adolescents with NF1 treated for STS in the Italian protocols between 1988 and
The symptom interval in children and adolescents with soft tissue sarcomas
β Scribed by Andrea Ferrari; Rosalba Miceli; Michela Casanova; Cristina Meazza; Francesca Favini; Roberto Luksch; Serena Catania; Marco Fiore; Carlo Morosi; Luigi Mariani
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 185 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The experience of one institution in treating soft tissue sarcomas of the head and neck in a pediatric population is presented. ## METHODS. Case materials of 134 patients younger than 20 years who were referred to the University of Texas M. D. Anderson Cancer Center between 1970
## Background. Because the natural history of pediatric patients with metastatic nonrhabdomyosarcomatous soft-tissue sarcomas (NRSTS) had not been well described, we retrospectively reviewed our single-institution experience with these tumors. Procedure. We identified 26 patients with metastatic N
## Abstract Fortyβseven children with nonrhabdomyosarcomatous softβtissue sarcomas (NRSTS) were treated by the HematologyβOncology Service at Texas Children's Hospital, Houston, Texas, between 1958 and 1990. The male: female ratio was 1:1, and the median age was 11 years (3 weeksβ16 years). A preex